Delivery Order SPE2DB20D2014-SPE2DB25FB81U
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Estradiol 0.01% Cream in 42.5-gram units. This is a firm fixed-price delivery order with a ceiling value of $1,563.30, with an ultimate completion date of September 17, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this order,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on July 22, 2025, with a ceiling value of $1,150.32 and an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on September 19, 2025, with a ceiling value of $1,114.92 and an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $6,211.59 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Estradiol 0.01% cream in 42.5-gram units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Estradiol 0.01% cream in 42.5 gram units, with a ceiling value of $3,720.99 and an ultimate completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram units, with a ceiling value of $2,357.79 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.76 to AmerisourceBergen Drug Corp for Estrace 0.01% Cream in a 42.5-gram quantity. This contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,201.20 to supply Estrace 0.01% Cream in a 42.5-gram unit, with an ultimate completion date of September 26, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estrace 0.01% Cream in a 42.5-gram formulation, valued at $1,145.09. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB81UDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,817.31 for Estradiol 0.01% Cream (42.5 grams) on May 2, 2025, with completion scheduled for May 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award exemplifies AmerisourceBergen's role as a critical pharmaceutical vendor within the Defense Logistics Agency's medical supply chain. The Estradiol cream delivery supports federal healthcare requirements across military and veteran systems. AmerisourceBergen's extensive IDC with DLA Troop Support Medical enables flexible procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, positioning the company to fulfill both routine pharmaceutical needs and specialized medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/2/25 |